Profile picture

Doctor Carlos Andres Plata Mosquera

Cardiovascular Hospital Centre Nou Delfos (CIEC), Barcelona (Spain)
Follow
Biography
Cardiologist specialized in advanced heart failure and heart transplantation, with certified training in echocardiography, CT coronary and cardiac resonance, and more than 15 years of experience in the study and treatment of cardiomyopathies. Director of the heart failure and heart transplant unit at the DIME Clínica Neurocardiovascular in Cali-Colombia (2011-2024), and leader of the research line REMODELING HF (analysis of the fibrotic process associated with ventricular remodeling in heart failure). He is currently the Coordinator of the Cardiology Department at HM Nou Delfos Hospital in Barcelona, Spain. Educational background: Cardiac-MRI and Coronary CT: Hospital de Sant Pau, 2015. Heart Failure and Heart Transplantation: Hospital Clínic, 2009-2010, Barcelona. Internal Medicine, Cardiology and Echocardiography: Pontificia Universidad Javeriana/Hospital Universitario San Ignacio, 2001-2008. Medical Degree: Universidad Militar Nueva Granada/Hospital Militar, Bogotá, Colombia, 1999.
Logo ESC

Contributor content

Empagliflozin reduces extracellular volume and myocardial sodium content in patients with heart failure and preserved ejection fraction and correlates with reverse cardiac remodeling (EMPAG CMR-HF)
Presentation
Empagliflozin reduces extracellular volume and myocardial sodium content in patients with heart failure and preserved ejection fraction and correlates with reverse cardiac remodeling (EMPAG CMR-HF)
Reduction of extracellular volume and reverse cardiac remodeling during sacubitril/valsartan therapy assessed by cardiac magnetic resonance in patients with heart failure (REMODELING CMR-HF)
Presentation
Reduction of extracellular volume and reverse cardiac remodeling during sacubitril/valsartan therapy assessed by cardiac magnetic resonance in patients with heart failure (REMODELING CMR-HF)